748/MSS_/Multiple Sclerosis Society/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2003	1
2004	35
2005	45
2006	44
2007	38
2008	28
2009	11
2024	0

1

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. Polman CH, et al. N Engl J Med. 2006 Mar 2;354(9):899-910. doi: 10.1056/NEJMoa044397. N Engl J Med. 2006. PMID: 16510744 Free article. Clinical Trial.

2

Primary-progressive multiple sclerosis.

Miller DH, Leary SM. Miller DH, et al. Lancet Neurol. 2007 Oct;6(10):903-12. doi: 10.1016/S1474-4422(07)70243-0. Lancet Neurol. 2007. PMID: 17884680 Review.

3

Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data.

Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE. Smith SM, et al. Neuroimage. 2006 Jul 15;31(4):1487-505. doi: 10.1016/j.neuroimage.2006.02.024. Epub 2006 Apr 19. Neuroimage. 2006. PMID: 16624579

4

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, Miller DH, Montalban X, Simon JH, Polman C, Filippi M. Charil A, et al. Lancet Neurol. 2006 Oct;5(10):841-52. doi: 10.1016/S1474-4422(06)70572-5. Lancet Neurol. 2006. PMID: 16987731 Review.

5

MRI in multiple sclerosis: current status and future prospects.

Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, Barkhof F, Inglese M, Guttmann CR, Horsfield MA, Filippi M. Bakshi R, et al. Lancet Neurol. 2008 Jul;7(7):615-25. doi: 10.1016/S1474-4422(08)70137-6. Lancet Neurol. 2008. PMID: 18565455 Free PMC article. Review.

6

Diffusion MRI in multiple sclerosis.

Rovaris M, Gass A, Bammer R, Hickman SJ, Ciccarelli O, Miller DH, Filippi M. Rovaris M, et al. Neurology. 2005 Nov 22;65(10):1526-32. doi: 10.1212/01.wnl.0000184471.83948.e0. Neurology. 2005. PMID: 16301477 Review.

7

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring.

Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB. Kappos L, et al. Lancet Neurol. 2007 May;6(5):431-41. doi: 10.1016/S1474-4422(07)70078-9. Lancet Neurol. 2007. PMID: 17434098 Review.

8

Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.

Miller DH. Miller DH. NeuroRx. 2004 Apr;1(2):284-94. doi: 10.1602/neurorx.1.2.284. NeuroRx. 2004. PMID: 15717029 Free PMC article. Review.

9

Recent advances in neuroimaging of multiple sclerosis.

Rashid W, Miller DH. Rashid W, et al. Semin Neurol. 2008 Feb;28(1):46-55. doi: 10.1055/s-2007-1019127. Semin Neurol. 2008. PMID: 18256986 Review.

10

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Polman CH, et al. Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703. Ann Neurol. 2005. PMID: 16283615 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

182 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year